glp-1 parkinson's disease drug shows little benefit for people with | UCL News A new Science Perspective highlights

glp-1 parkinson's disease

glp-1 parkinson's disease drug shows little benefit for people with | UCL News A new Science Perspective highlights

Name: glp-1 parkinson's disease drug shows little benefit for people with | UCL News A new Science Perspective highlights
Brand: neboallen.info
SKU: 95013289292
Price: 27.71 USD
Availability: InStock
Rating: 4.7353000000000005 (14 reviews)

SKU: 95013289292

4.7

EUR27.71 EUR76.71

Pay in 4 interest-free payments of $6.93 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

Ibe C, Munro CA

Market Opportunities Expansion into Emerging Markets:The GCC region's emerging markets present a significant opportunity for GLP-1 agonists

These treatments mimic a natural hormone called GLP-1 that helps regulate appetite, insulin, and blood sugar (2)

For readers following community views on Eli Lilly, the focus has been on how the company uses its obesity and diabetes success to reduce reliance on a handful of drugs and build a pipeline that can matter beyond current blockbusters.